基本资料
投资组合
财务数据
基金公告
广发生物科技指数美元(QDII)C(016471) |
净值:
0.2091
|
日增长率:
1.78%
|
累计净值:0.2091 | 2026-04-30 |
|
|
||||
| 股票代码 | 股票简称 | 持股数量(股) | 持股市值(元) | 占基金净值比(%) |
| GILD | 吉利德科学 | 19,408.00 | 18,716,236.35 | 8.66 |
| VRTX | 福泰制药 | 5,633.00 | 17,404,780.74 | 8.05 |
| AMGN | 安进 | 7,070.00 | 17,212,557.59 | 7.96 |
| REGN | 再生元制药 | 2,319.00 | 12,397,849.90 | 5.74 |
| ALNY | Alnylam Pharmaceuticals Inc | 2,967.00 | 6,792,714.71 | 3.14 |
| INSM | Insmed Inc | 4,790.00 | 5,419,694.78 | 2.51 |
| BIIB | 生化基因 | 3,295.00 | 4,179,818.22 | 1.93 |
| UTHR | 联合治疗 | 967.00 | 3,967,664.64 | 1.84 |
| ARGX | argenx SE ADR | 653.00 | 3,299,538.38 | 1.53 |
| RPRX | Royalty Pharma plc-A | 9,596.00 | 3,185,139.04 | 1.47 |
| 报告期 | 股票占净比(%) | 债券占净比(%) | 现金占净比(%) | 净资产(元) |
| 2026-03-31 | 84.93 | - | 6.22 | 216,164,128.25 |
| 2025-12-31 | 77.88 | - | 10.39 | 206,327,611.27 |
| 2025-09-30 | 80.39 | - | 7.10 | 179,555,484.90 |
| 2025-06-30 | 80.14 | - | 7.05 | 191,910,562.78 |
| 2025-03-31 | 79.19 | - | 7.41 | 199,405,817.70 |